Compare MKC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKC | ASND |
|---|---|---|
| Founded | 1889 | 2006 |
| Country | United States | Denmark |
| Employees | 14100 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 14.7B |
| IPO Year | N/A | 2014 |
| Metric | MKC | ASND |
|---|---|---|
| Price | $53.51 | $241.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $67.00 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 5.4M | 477.7K |
| Earning Date | 03-31-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.12 | $97.60 |
| Revenue Next Year | $3.76 | $43.64 |
| P/E Ratio | $23.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.52 | $151.11 |
| 52 Week High | $78.03 | $250.74 |
| Indicator | MKC | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 44.68 | 58.32 |
| Support Level | $47.52 | $190.49 |
| Resistance Level | $69.16 | $248.60 |
| Average True Range (ATR) | 1.98 | 9.71 |
| MACD | 0.85 | 2.58 |
| Stochastic Oscillator | 83.24 | 74.86 |
In its 135-plus-year history, McCormick has become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base includes quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. Its reach is extensive, with nearly 40% of sales generated beyond its home turf to 150 countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.